Clinical significance of miRNA-433 expression in hepatocellular carcinoma

Background: Previous studies found miRNAs can play important role in the pathogenesis, metastasis and prognosis of hepatocellular carcinoma by regulating the expression of its target genes. We evaluated the clinical significance of miRNA-433 expression in hepatocellular carcinoma. Method: We collected 28 primary hepatocellular carcinoma specimens matched by 28 normal paracarcinoma tissues. The RNA concentration was calculated by the following formula: OD260 × 50 times × 40/100. We detected the absorbance at 260 nm and 280 nm, and calculated OD260/OD280. The purity was considered to be acceptable when the ratio value fallen into between 1.8 and 2.0. The expression of MiR-433 was analysed via Real time-PCR method. The Cq value was calculated, and Data were processed using 2-ΔΔCT method. Results: According to the 2-ΔΔCT method, the expression of miR-433 in the hepatocellular carcinoma specimens was significantly lower than that in the normal tissue specimens (3.61 ± 1.35 vs. 9.39 ± 2.46, t=-10.899, P<0.001). The receiver operating characteristic cure was used to identify the diagnostic value of miR-433 expression levels in hepatocellular carcinoma. The area under curve of miR-433 was 0.770 (95% confidence interval: 0.594-0.947). Conclusion: The low expression of miR-433 in hepatocellular carcinoma may be related to occurrence of hepatocellular carcinoma. miR-433 expression might have a moderately diagnostic value to hepatocellular carcinoma.

[1]  O. Shaker,et al.  miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma. , 2017, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[2]  C. Wang,et al.  miRNA-370 acts as a tumor suppressor via the downregulation of PIM1 in hepatocellular carcinoma. , 2017, European review for medical and pharmacological sciences.

[3]  C. Xiao,et al.  miRNA-320a inhibits tumor proliferation and invasion by targeting c-Myc in human hepatocellular carcinoma , 2017, OncoTargets and therapy.

[4]  C. la Vecchia,et al.  Global trends and predictions in ovarian cancer mortality. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Liangfang Shen,et al.  Epithelial membrane protein 3 regulates TGF-β signaling activation in CD44-high glioblastoma , 2016, Oncotarget.

[6]  Liangfang Shen,et al.  Clinical utility of microRNA-378 as early diagnostic biomarker of human cancers: a meta-analysis of diagnostic test , 2016, Oncotarget.

[7]  F. Slack,et al.  Combinatorial Action of MicroRNAs let-7 and miR-34 Effectively Synergizes with Erlotinib to Suppress Non-small Cell Lung Cancer Cell Proliferation , 2015, Cell cycle.

[8]  Youwen Tan,et al.  A Serum MicroRNA Panel as Potential Biomarkers for Hepatocellular Carcinoma Related with Hepatitis B Virus , 2014, PloS one.

[9]  S. Shete,et al.  MicroRNA target site polymorphisms in the VHL‐HIF1α pathway predict renal cell carcinoma risk , 2014, Molecular carcinogenesis.

[10]  Jianxun Song,et al.  Hepatitis B Virus X Protein-Induced Aberrant Epigenetic Modifications Contributing to Human Hepatocellular Carcinoma Pathogenesis , 2013, Molecular and Cellular Biology.

[11]  Sung-Chou Li,et al.  Epigenetic regulation of miR‐34b and miR‐129 expression in gastric cancer , 2011, International journal of cancer.

[12]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[13]  Kazuhiro Yoshida,et al.  Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. , 2010, The Lancet. Oncology.

[14]  A. Jemal,et al.  Cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[15]  K. Tao,et al.  Down-regulation of microRNA-433 expression in gastric cancer: Possible mechanisms involved , 2012 .

[16]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.